Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioblastoma | 21 | 2023 | 3481 | 1.020 |
Why?
|
Brain Neoplasms | 22 | 2023 | 8863 | 0.690 |
Why?
|
Drug Resistance, Neoplasm | 14 | 2023 | 5172 | 0.590 |
Why?
|
Fusion Proteins, bcr-abl | 7 | 2010 | 434 | 0.520 |
Why?
|
Ovarian Neoplasms | 11 | 2023 | 4838 | 0.470 |
Why?
|
Neoplastic Stem Cells | 5 | 2019 | 1376 | 0.370 |
Why?
|
Cell Line, Tumor | 33 | 2023 | 16689 | 0.370 |
Why?
|
Oncolytic Virotherapy | 4 | 2023 | 498 | 0.360 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2022 | 8428 | 0.360 |
Why?
|
MicroRNAs | 8 | 2022 | 3752 | 0.340 |
Why?
|
Cell Movement | 10 | 2019 | 5217 | 0.330 |
Why?
|
Aldehyde Dehydrogenase | 2 | 2019 | 142 | 0.320 |
Why?
|
Lithium Chloride | 1 | 2008 | 87 | 0.320 |
Why?
|
Paclitaxel | 5 | 2022 | 1708 | 0.310 |
Why?
|
Cisplatin | 5 | 2022 | 1662 | 0.300 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 430 | 0.300 |
Why?
|
Antineoplastic Agents | 11 | 2023 | 13695 | 0.300 |
Why?
|
Cytomegalovirus Infections | 3 | 2021 | 820 | 0.300 |
Why?
|
Glioma | 6 | 2013 | 3401 | 0.280 |
Why?
|
DNA Repair | 6 | 2010 | 2046 | 0.260 |
Why?
|
Exosomes | 3 | 2021 | 417 | 0.250 |
Why?
|
Spheroids, Cellular | 5 | 2023 | 351 | 0.240 |
Why?
|
Cell Proliferation | 12 | 2019 | 10481 | 0.240 |
Why?
|
Elasticity Imaging Techniques | 2 | 2020 | 388 | 0.240 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2010 | 689 | 0.220 |
Why?
|
Herpesvirus 1, Human | 2 | 2023 | 743 | 0.210 |
Why?
|
Immunotherapy | 5 | 2022 | 4445 | 0.210 |
Why?
|
Cytomegalovirus | 2 | 2019 | 732 | 0.200 |
Why?
|
Polyunsaturated Alkamides | 1 | 2021 | 29 | 0.200 |
Why?
|
Oncolytic Viruses | 2 | 2023 | 327 | 0.190 |
Why?
|
Benzodioxoles | 1 | 2021 | 69 | 0.190 |
Why?
|
Neoplasm Invasiveness | 8 | 2016 | 3616 | 0.190 |
Why?
|
Neoplasm Proteins | 5 | 2019 | 3703 | 0.190 |
Why?
|
Mice, Nude | 9 | 2020 | 3689 | 0.190 |
Why?
|
Reactive Oxygen Species | 2 | 2006 | 2077 | 0.180 |
Why?
|
Alkaloids | 1 | 2021 | 190 | 0.180 |
Why?
|
Cell Adhesion | 5 | 2019 | 3144 | 0.180 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2019 | 24 | 0.170 |
Why?
|
Drug Resistance, Multiple | 2 | 2017 | 252 | 0.170 |
Why?
|
Killer Cells, Natural | 2 | 2022 | 2133 | 0.170 |
Why?
|
Granulosa Cells | 1 | 2019 | 120 | 0.170 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2018 | 60 | 0.160 |
Why?
|
DNA Damage | 6 | 2006 | 2432 | 0.160 |
Why?
|
Osmium | 1 | 2017 | 19 | 0.160 |
Why?
|
Mice | 31 | 2023 | 81183 | 0.160 |
Why?
|
Vault Ribonucleoprotein Particles | 1 | 2017 | 11 | 0.150 |
Why?
|
Neovascularization, Pathologic | 3 | 2019 | 2635 | 0.150 |
Why?
|
Cell Survival | 10 | 2021 | 5882 | 0.150 |
Why?
|
Tumor Escape | 1 | 2020 | 349 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2021 | 578 | 0.150 |
Why?
|
Cell Communication | 2 | 2021 | 1621 | 0.140 |
Why?
|
Automation | 1 | 2019 | 584 | 0.140 |
Why?
|
Indolizines | 1 | 2016 | 37 | 0.140 |
Why?
|
Brefeldin A | 1 | 2016 | 72 | 0.140 |
Why?
|
Pericytes | 1 | 2019 | 292 | 0.140 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 197 | 0.140 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3586 | 0.140 |
Why?
|
Coordination Complexes | 1 | 2017 | 115 | 0.140 |
Why?
|
Collagen Type III | 3 | 2021 | 90 | 0.130 |
Why?
|
Retinal Dehydrogenase | 3 | 2021 | 74 | 0.130 |
Why?
|
Animals | 37 | 2023 | 168757 | 0.130 |
Why?
|
Collagen Type I | 1 | 2018 | 592 | 0.130 |
Why?
|
Cell Culture Techniques | 2 | 2021 | 1678 | 0.130 |
Why?
|
Tunicamycin | 1 | 2015 | 112 | 0.130 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 440 | 0.130 |
Why?
|
Extracellular Matrix | 2 | 2020 | 1741 | 0.130 |
Why?
|
Antibodies, Bispecific | 1 | 2017 | 164 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 2 | 2021 | 849 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2019 | 3557 | 0.120 |
Why?
|
Dexamethasone | 1 | 2022 | 1951 | 0.120 |
Why?
|
Down-Regulation | 2 | 2019 | 3002 | 0.120 |
Why?
|
Topotecan | 3 | 2019 | 137 | 0.110 |
Why?
|
Genomic Instability | 2 | 2010 | 695 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1276 | 0.110 |
Why?
|
Morphogenesis | 1 | 2017 | 752 | 0.110 |
Why?
|
RecQ Helicases | 2 | 2010 | 54 | 0.110 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2014 | 131 | 0.110 |
Why?
|
Suppression, Genetic | 1 | 2013 | 196 | 0.110 |
Why?
|
Piperidines | 1 | 2021 | 1602 | 0.110 |
Why?
|
Morpholines | 1 | 2016 | 571 | 0.110 |
Why?
|
Tumor Cells, Cultured | 4 | 2013 | 6314 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2019 | 3920 | 0.110 |
Why?
|
NF-kappa B | 1 | 2021 | 2499 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2022 | 2107 | 0.110 |
Why?
|
Oocytes | 1 | 2017 | 1187 | 0.100 |
Why?
|
Aminopyridines | 1 | 2016 | 542 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2016 | 3798 | 0.100 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2013 | 599 | 0.100 |
Why?
|
STAT5 Transcription Factor | 1 | 2012 | 259 | 0.100 |
Why?
|
STAT3 Transcription Factor | 2 | 2013 | 873 | 0.090 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2014 | 560 | 0.090 |
Why?
|
Rad51 Recombinase | 3 | 2006 | 189 | 0.090 |
Why?
|
Ionic Liquids | 1 | 2010 | 9 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2038 | 0.090 |
Why?
|
Exodeoxyribonucleases | 1 | 2010 | 180 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 484 | 0.090 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2010 | 205 | 0.090 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 471 | 0.090 |
Why?
|
Gene Expression Profiling | 6 | 2022 | 9438 | 0.080 |
Why?
|
Cell Cycle | 3 | 2008 | 2967 | 0.080 |
Why?
|
Valproic Acid | 1 | 2012 | 445 | 0.080 |
Why?
|
Simplexvirus | 2 | 2012 | 802 | 0.080 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2008 | 37 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1028 | 0.080 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 437 | 0.080 |
Why?
|
Humans | 48 | 2023 | 744343 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 35421 | 0.080 |
Why?
|
Recombination, Genetic | 4 | 2006 | 1586 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3508 | 0.070 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 789 | 0.070 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2010 | 611 | 0.070 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 453 | 0.070 |
Why?
|
Organ Culture Techniques | 1 | 2008 | 813 | 0.070 |
Why?
|
Blotting, Western | 3 | 2008 | 5179 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3617 | 0.070 |
Why?
|
Signal Transduction | 9 | 2017 | 23403 | 0.070 |
Why?
|
Phosphoproteins | 2 | 2006 | 2440 | 0.070 |
Why?
|
Up-Regulation | 4 | 2021 | 4217 | 0.070 |
Why?
|
JC Virus | 1 | 2006 | 85 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4042 | 0.070 |
Why?
|
Antigens, Viral, Tumor | 1 | 2006 | 154 | 0.070 |
Why?
|
Optics and Photonics | 1 | 2007 | 321 | 0.070 |
Why?
|
Transgenes | 1 | 2009 | 1009 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2013 | 812 | 0.060 |
Why?
|
Comet Assay | 1 | 2004 | 71 | 0.060 |
Why?
|
NIH 3T3 Cells | 2 | 2019 | 677 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2866 | 0.060 |
Why?
|
Interphase | 1 | 2004 | 226 | 0.060 |
Why?
|
Female | 22 | 2023 | 380194 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2849 | 0.060 |
Why?
|
Receptor, Insulin | 2 | 2006 | 846 | 0.060 |
Why?
|
Antigens, CD | 1 | 2013 | 4026 | 0.060 |
Why?
|
Blast Crisis | 1 | 2003 | 103 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5510 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 139 | 0.050 |
Why?
|
Gamma Rays | 2 | 2019 | 320 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2010 | 1403 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2022 | 1708 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2375 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
Mutagenesis | 1 | 2006 | 1266 | 0.050 |
Why?
|
Oximes | 1 | 2023 | 311 | 0.050 |
Why?
|
Receptor, IGF Type 1 | 1 | 2003 | 390 | 0.050 |
Why?
|
Blood Cells | 1 | 2003 | 309 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 478 | 0.050 |
Why?
|
RNA Interference | 3 | 2022 | 2889 | 0.050 |
Why?
|
Adenosine Triphosphatases | 1 | 2005 | 839 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2008 | 1351 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2010 | 2455 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9274 | 0.050 |
Why?
|
Length of Stay | 1 | 2013 | 6309 | 0.050 |
Why?
|
Subtraction Technique | 1 | 2003 | 525 | 0.050 |
Why?
|
DNA Helicases | 1 | 2005 | 859 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2014 | 2948 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 21683 | 0.040 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2003 | 651 | 0.040 |
Why?
|
Leukemia | 2 | 2005 | 1511 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2009 | 1861 | 0.040 |
Why?
|
Biological Transport | 2 | 2014 | 2118 | 0.040 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10180 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10252 | 0.040 |
Why?
|
Phosphotyrosine | 1 | 2019 | 457 | 0.040 |
Why?
|
Phosphorylation | 3 | 2021 | 8436 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2014 | 3505 | 0.040 |
Why?
|
HeLa Cells | 2 | 2017 | 3128 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2008 | 3023 | 0.040 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 59 | 0.040 |
Why?
|
Viscosity | 1 | 2017 | 328 | 0.040 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 503 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 200 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2006 | 2969 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1990 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2019 | 625 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2017 | 408 | 0.030 |
Why?
|
Histone Demethylases | 1 | 2019 | 321 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1012 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4554 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5256 | 0.030 |
Why?
|
Sus scrofa | 1 | 2017 | 437 | 0.030 |
Why?
|
Lymphokines | 1 | 2019 | 949 | 0.030 |
Why?
|
Elasticity | 1 | 2017 | 657 | 0.030 |
Why?
|
Gene Expression | 3 | 2014 | 7799 | 0.030 |
Why?
|
Mutation | 6 | 2021 | 29786 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2016 | 2382 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2003 | 2015 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6773 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2003 | 2513 | 0.030 |
Why?
|
Protein Transport | 2 | 2016 | 1988 | 0.030 |
Why?
|
Vimentin | 1 | 2016 | 261 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6538 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2019 | 19229 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2019 | 627 | 0.030 |
Why?
|
Dacarbazine | 1 | 2017 | 566 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 934 | 0.030 |
Why?
|
Transfection | 3 | 2010 | 5892 | 0.030 |
Why?
|
Phenotype | 4 | 2017 | 16365 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2727 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2017 | 652 | 0.030 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2013 | 87 | 0.030 |
Why?
|
Poland | 1 | 2013 | 184 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2008 | 5853 | 0.030 |
Why?
|
Time Factors | 5 | 2017 | 40075 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2013 | 475 | 0.030 |
Why?
|
Neuroglia | 1 | 2019 | 927 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 730 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 2007 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 3386 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2010 | 1213 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9583 | 0.030 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2006 | 563 | 0.030 |
Why?
|
Glycosylation | 1 | 2015 | 1126 | 0.030 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2013 | 221 | 0.030 |
Why?
|
Cell Migration Assays | 1 | 2011 | 23 | 0.030 |
Why?
|
Cyclic S-Oxides | 1 | 2011 | 21 | 0.030 |
Why?
|
Anthraquinones | 1 | 2011 | 37 | 0.030 |
Why?
|
Antibodies | 1 | 2020 | 2460 | 0.030 |
Why?
|
Gastroparesis | 1 | 2013 | 131 | 0.030 |
Why?
|
Gastric Emptying | 1 | 2013 | 233 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2715 | 0.030 |
Why?
|
Drug Synergism | 1 | 2016 | 1792 | 0.030 |
Why?
|
Myosin Type II | 1 | 2011 | 68 | 0.030 |
Why?
|
Cell Death | 1 | 2017 | 1706 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2010 | 3701 | 0.020 |
Why?
|
Disease Progression | 2 | 2010 | 13284 | 0.020 |
Why?
|
Nanofibers | 1 | 2011 | 66 | 0.020 |
Why?
|
Polystyrenes | 1 | 2011 | 112 | 0.020 |
Why?
|
Base Sequence | 3 | 2009 | 12797 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2017 | 951 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18029 | 0.020 |
Why?
|
Carcinoma, Endometrioid | 1 | 2013 | 271 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.020 |
Why?
|
Toxicity Tests, Chronic | 1 | 2010 | 7 | 0.020 |
Why?
|
Annexin A5 | 1 | 2010 | 103 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1538 | 0.020 |
Why?
|
Microtubules | 1 | 2016 | 1090 | 0.020 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2013 | 506 | 0.020 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2013 | 450 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2085 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2005 | 9648 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1017 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2480 | 0.020 |
Why?
|
Computational Biology | 1 | 2022 | 3521 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2010 | 459 | 0.020 |
Why?
|
Digestive System | 1 | 2010 | 253 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 403 | 0.020 |
Why?
|
Microcirculation | 1 | 2013 | 1286 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5917 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1655 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 9338 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19905 | 0.020 |
Why?
|
Cell Line | 3 | 2012 | 15997 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2234 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2010 | 528 | 0.020 |
Why?
|
Histone Deacetylase 1 | 1 | 2009 | 137 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2012 | 1369 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1903 | 0.020 |
Why?
|
Glucose | 2 | 2010 | 4397 | 0.020 |
Why?
|
COS Cells | 1 | 2010 | 1161 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10943 | 0.020 |
Why?
|
Blood Vessels | 1 | 2013 | 1125 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2010 | 708 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2008 | 862 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3870 | 0.020 |
Why?
|
Chemotaxis | 1 | 2009 | 607 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2005 | 20 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2010 | 1901 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2010 | 594 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2009 | 893 | 0.020 |
Why?
|
Genes, abl | 1 | 2005 | 72 | 0.020 |
Why?
|
DNA, Antisense | 1 | 2005 | 46 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3647 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7913 | 0.020 |
Why?
|
Methylnitronitrosoguanidine | 1 | 2004 | 20 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2010 | 1758 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7880 | 0.020 |
Why?
|
Oncogene Proteins v-abl | 1 | 2004 | 22 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2534 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2010 | 1081 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 2008 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 1157 | 0.020 |
Why?
|
Organ Size | 1 | 2010 | 2252 | 0.020 |
Why?
|
Tissue Scaffolds | 1 | 2011 | 956 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2892 | 0.020 |
Why?
|
Mutagens | 1 | 2004 | 168 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2009 | 728 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2005 | 876 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2010 | 1813 | 0.010 |
Why?
|
Brain Diseases | 1 | 2013 | 1563 | 0.010 |
Why?
|
Actins | 1 | 2011 | 2121 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 5021 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2925 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2012 | 3206 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2004 | 898 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 1312 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
Protein Kinases | 1 | 2010 | 1640 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6234 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2023 | 63114 | 0.010 |
Why?
|
Indoles | 1 | 2011 | 1839 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12951 | 0.010 |
Why?
|
Rats | 2 | 2010 | 24260 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 18111 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2010 | 1988 | 0.010 |
Why?
|
DNA, Viral | 1 | 2009 | 2225 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3772 | 0.010 |
Why?
|
Sulfonamides | 1 | 2011 | 1938 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 2004 | 707 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1970 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2006 | 2256 | 0.010 |
Why?
|
Mice, SCID | 1 | 2006 | 2716 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 2187 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 2307 | 0.010 |
Why?
|
Benzamides | 1 | 2006 | 1379 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11366 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11483 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2010 | 3086 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4669 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14557 | 0.010 |
Why?
|
Palliative Care | 1 | 2013 | 3493 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2699 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4253 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6473 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2751 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9727 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4186 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20129 | 0.010 |
Why?
|
Piperazines | 1 | 2006 | 2488 | 0.010 |
Why?
|
Biopsy | 1 | 2007 | 6756 | 0.010 |
Why?
|
Liver | 1 | 2010 | 7474 | 0.010 |
Why?
|
Models, Genetic | 1 | 2004 | 3494 | 0.010 |
Why?
|
Pyrimidines | 1 | 2006 | 2942 | 0.010 |
Why?
|
Transcription Factors | 1 | 2013 | 12208 | 0.010 |
Why?
|
Fibroblasts | 1 | 2003 | 4161 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 13033 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 5102 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10638 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 29144 | 0.010 |
Why?
|
Lung | 1 | 2010 | 9856 | 0.010 |
Why?
|
Protein Binding | 1 | 2003 | 9386 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7301 | 0.010 |
Why?
|
Male | 3 | 2013 | 350118 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8949 | 0.010 |
Why?
|
Middle Aged | 2 | 2013 | 213383 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 53288 | 0.010 |
Why?
|
Algorithms | 1 | 2007 | 13881 | 0.000 |
Why?
|
Aged | 1 | 2013 | 163280 | 0.000 |
Why?
|